International Clinical Trial: A post marketing surveillance study to evaluate the safety and effectiveness of semaglutide in adults with overweight or obesity in routine clinical practice

Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (CTRI/2026/10/119296) titled 'A post marketing surveillance study to evaluate the safety and effectiveness of semaglutide in adults with overweight or obesity in routine clinical practice' on Oct. 9.

Study Type: PMS

Study Design: Single Arm Study Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Not Applicable

Primary Sponsor: Novo Nordisk India Private Limited

Condition: Health Condition 1: E669- Obesity, unspecified Health Condition 2: E668- Other obesity Health Condition 3: E663- Overweight

Intervention: Intervention1: NIL: NIL Intervention2: NA: ...